Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Active, Not Recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

NCT06390995

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 20 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer, +46 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute - Lake Mary Lake Mary, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

NCT03448042

Conditions
Solid Tumors
Locations
  • Yale University New Haven, Connecticut, United States
  • Washington University Saint Louis, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

NCT02320435

Conditions
Solid Tumors
Locations
  • Santa Casa de Misericordia de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • Hospital Amaral Carvalho Jaú, São Paulo, Brazil
  • Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo, Brazil
  • Hospital Sírio-Libanês São Paulo, Brazil
View all 61 locations
View Trial Details
Active, Not Recruiting

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

NCT04589845

Conditions
Solid Tumors
Locations
  • Western Regional Medical Center at Cancer Treatment Centers of America Goodyear, Arizona, United States
  • Kaiser Permanente Los Angeles Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 114 locations
View Trial Details
Active, Not Recruiting

Phase I Comparative Bioavailability Study

NCT00777582

Conditions
Solid Tumors
Locations
  • Research Site Randwick, Australia
  • Research Site Leuven, Belgium
  • Research Site Bellinzona, Switzerland
  • Research Site Edinburgh, United Kingdom
View Trial Details

Related conditions